• $2.0M
    Market Cap
  • -55.74%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2022
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
18.6M
-8.67%
20.4M
-4.60%
21.4M
N/A
Cost of Revenue
7.1M
-16.22%
8.5M
-2.49%
8.7M
N/A
Gross Profit
11.5M
-3.30%
11.9M
-6.05%
12.7M
N/A
Sales and Marketing Expense
6.5M
-6.79%
7.0M
+7.21%
6.5M
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
137,403
+103.14%
67,638
-35.05%
104,143
N/A
Total Operating Expenses
12.4M
-12.56%
14.1M
+2.91%
13.7M
N/A
Operating Profit
-815,072
-62.88%
-2.2M
+113.59%
-1.0M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-171,294
+118.96%
-78,230
-17.61%
-94,953
N/A
Interest Income and Expense and Net
-171,294
+118.96%
-78,230
-17.61%
-94,953
N/A
Total Nonoperating Income and Expense
3.9M
+529.55%
625,338
+262.18%
-385,588
N/A
Income before Taxes
3.1M
+298.82%
-1.6M
+11.08%
-1.4M
N/A
Income Taxes
23,655
+33.47%
17,723
-6.69%
18,993
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
3.1M
+295.11%
-1.6M
+10.85%
-1.4M
N/A
Net Income from Continuing Operations Applicable to Common
3.1M
+298.82%
-1.6M
+9.61%
-1.4M
N/A
Basic EPS and Net Income
0.04
+300.00%
-0.02
0.00%
-0.02
N/A
Diluted EPS and Net Income
0.04
+300.00%
-0.02
0.00%
-0.02
N/A
Basic Weighted Average Shares
70.3M
0.00%
70.3M
+0.14%
70.2M
N/A
Diluted Weighted Average Shares
77.9M
+10.72%
70.3M
+0.14%
70.2M
N/A
Balance Sheet
Cash and Cash Equivalents
147,854
-73.27%
553,190
-53.41%
1.2M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
147,854
-73.27%
553,190
-53.41%
1.2M
N/A
Total Current Assets
13.8M
+7.33%
12.8M
+1.61%
12.6M
N/A
Accumulated Depreciation
19,540
+50.33%
12,998
-59.54%
32,127
N/A
Property and Plant and Equipment and Net
709
-90.22%
7,251
-59.24%
17,791
N/A
Total Long-Term Assets
709
-90.22%
7,251
-59.24%
17,791
N/A
Total Assets
19.8M
+7.97%
18.3M
+5.08%
17.4M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
2.0M
-22.67%
2.6M
+142.89%
1.1M
N/A
Total Current Liabilities
12.4M
+24.59%
9.9M
+37.17%
7.2M
N/A
Total Long-Term Debt
200,000
0.00%
200,000
0.00%
200,000
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
20.1M
-7.65%
21.7M
+11.29%
19.5M
N/A
Retained Earnings
-2.5M
-55.16%
-5.6M
+39.42%
-4.0M
N/A
Total Stockholders Equity
-310,854
-90.94%
-3.4M
+62.43%
-2.1M
N/A
Total Shares Outstanding
73.9M
+1.37%
72.9M
-0.31%
73.1M
N/A
Cash Flow
Cash from Operating Activities
34,799
+101.96%
-1.8M
-851.45%
236,654
N/A
Capital Expenditures
N/A
N/A
20,757
0.00%
20,757
N/A
Cash from Investing Activities
N/A
N/A
-20,757
0.00%
-20,757
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-440,135
-138.47%
1.1M
+995.55%
-127,749
N/A
Financials Ratio
Gross Margin
61.90%
+5.88%
58.47%
-1.52%
59.37%
N/A
Operating Margin
-4.37%
-59.35%
-10.75%
+123.89%
-4.80%
N/A
Return on Assets
16.28%
+283.10%
-8.89%
+11.09%
-8.00%
N/A
Return on Equity
-165.56%
-389.05%
57.28%
-33.33%
85.91%
N/A
Revenue Growth
-8.67%
+88.37%
-4.60%
-29.81%
-6.56%
N/A
Current Ratio
1.11
-13.85%
1.29
-25.92%
1.74
N/A
Cash Ratio
0.01
-78.60%
0.06
-66.06%
0.16
N/A
Debt-to-Equity Ratio
-7.07
+771.64%
-0.81
+35.62%
-0.60
N/A
Debt-to-Assets Ratio
0.11
-26.84%
0.15
+109.66%
0.07
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow